Burning Rock Biotech Limited Current Income Tax Expense (Benefit)
Burning Rock Biotech Limited (BNR) reported Current Income Tax Expense (Benefit) of CNY 1.56 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-04-28
CNY
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.56M CNY 20-F · filed 2026-04-28 | |
| 2024-12-31 | 5.88M CNY 20-F · filed 2026-04-28 | |
| 2023-12-31 | 2.39M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 1.99M CNY 20-F · filed 2025-04-29 | |
| 2021-12-31 | 899.00K CNY 20-F · filed 2024-04-29 | -899.00K CNY 20-F · filed 2022-04-29 |
| 2020-12-31 | 0.00 CNY 20-F · filed 2023-04-20 | |
| 2019-12-31 | 0.00 CNY 20-F · filed 2022-04-29 |
USD
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $223.00K 20-F · filed 2026-04-28 |
| 2024-12-31 | $806.00K 20-F · filed 2025-04-29 |
| 2023-12-31 | $336.00K 20-F · filed 2024-04-29 |
| 2022-12-31 | $288.00K 20-F · filed 2023-04-20 |
| 2021-12-31 | -$141.00K 20-F · filed 2022-04-29 |